In most organ systems, regeneration is a coordinated effort that involves many stem cells, but little is known about whether and how individual stem cells compensate for the functional deficiencies of other stem cells.
Introduction
Hematopoietic stem cells (HSCs) are widely scattered throughout the body in dispersed bone marrow niches 1, 2 .
Yet they must work together to maintain a common pool of peripheral blood cells. We have recently shown that HSCs can adapt their differentiation programs to the presence of other HSCs at various transplantation doses to ensure overall balanced blood production 3 . A similar coordination mechanism may allow healthy HSCs to rescue the functional deficiencies of impaired HSCs.
It is critically important to understand how the functional deficiencies of a subset of HSCs impact the overall HSC network. Many hematopoietic diseases arise from either an abnormal abundance (i.e., myeloproliferative disorder, thrombocytosis, leukocytosis, and erythrocytosis) or an abnormal deficiency (i.e., myelodysplastic syndrome, neutropenia, agranulocytosis, and thrombocytopenia) of certain blood cell types [4] [5] [6] .
The initial stages of these diseases may involve a latent period when a patient's healthy HSCs can sufficiently compensate for the deficiencies of diseased cells and ameliorate disease symptoms. Moreover, the primary treatment for many of these diseases, bone marrow transplantation 7 , also requires donor HSCs to adapt their differentiation programs to the disease environment. HSC compensation, especially in the lymphoid lineages, may play a role in aging as it is common for lymphopoietic deficiencies to develop in the elderly 8, 9 . Very few studies have attempted to understand the innate compensation capacity of stem cell networks. In this study, we offer new insights on HSC compensation mechanisms at the cellular and molecular levels.
While a single HSC is capable of regenerating the entire blood and immune system under extreme circumstances [10] [11] [12] , limiting dilution assays of HSC transplantation show that the number of donor HSCs quantitatively determines the fraction of blood cells that they produced 13, 14 . This suggests a simple coordination model, where individual HSCs play equal roles in contributing to blood regeneration after transplantation.
Recent work from our group and others have shown that HSC differentiation is heterogeneous at the clonal level 10, [15] [16] [17] [18] [19] . For example, individual HSC clones supply differential amounts of blood cells in mice and in human patients 17, 18, 20, 21 . Moreover, recent studies of native hematopoiesis suggest that different blood cell types have distinct clonal origins 22 . These new findings raise the question of how the diverse differentiation programs of individual HSCs are coordinated in the aftermath of functional disruptions. In this study, we use a cotransplantation experimental model and high throughput genetic barcode tracking technology to simultaneously quantify the in vivo differentiation of many individual HSCs. We show how normal HSCs compensate for genetically mutated HSCs that are deficient in supplying one or multiple types of lymphocytes (Fig 1) .
Results
To determine if HSCs functionally compensate for each other within an organism, we co-transplanted wild type (WT) HSCs with lineage-deficient HSCs into WT recipient mice (Fig 1) . Lineage-deficient HSCs were isolated from uMT -/mice that are unable to produce B cells, and from NSG and Rag2 -/γc -/mice that are unable to produce both B and T cells ( Fig 2B, 2E , Appendix Figure S1B , 1E, EV Fig 1) . We examined the peripheral blood of the recipient mice 6-8 months post transplantation when blood production had returned to a steady state ( Fig 1) 14, 23 . We found that WT HSCs compensated for the deficiencies of their partner HSCs in distinct patterns. In the uMT -/co-transplantation group, WT HSCs significantly oversupplied B cells (Fig 2A, Appendix Figure S1A ). This suggests that the presence of lineage-deficient HSCs changed the differentiation of WT HSCs within a common host. Moreover, we found that the presence of WT HSCs also changed the differentiation of lineage-deficient HSCs. For example, uMT -/mice have normal levels of T cells (EV Fig 1) , but uMT -/-HSCs produced fewer T cells in the co-transplantation setting ( Fig 2B, Appendix Figure S1B ). The reduction in B and T cell production by uMT -/-HSCs was compensated by an oversupply from WT HSCs such that the overall B and T cell levels remained normal ( Fig 2C, Appendix Figure S1C ). In the Rag2 -/γc -/and NSG co-transplantation groups, WT HSCs significantly oversupplied B cells, CD4 T and CD8 T cells ( To determine if lymphopoietic compensation originates from an increase in the number of differentiating HSCs or from an elevated expansion of their differentiation, we used a genetic barcoding technique that we have developed to track WT donor HSCs at the clonal level ( Fig 1) 17 . We found that the total numbers of WT HSC clones that supply the myeloid and lymphoid lineages were similar between the control and co-transplantation groups (Fig 3, Appendix Figure S2 ). To compare HSC clonal expansion, we classified HSC clones by the quantity of their blood cell production. We found that significantly more HSC clones produced high amounts of B cells in the uMT -/co-transplantation group, and high amounts of B and T cells in the NSG and Rag2 -/γc -/co-transplantation group (Fig 4B, 4F -H, Appendix Figure S3B , 3F-H). The increase in clonal expansion was not observed in the granulocyte population ( Fig 4A, 4E , Appendix Figure S3A , 3E). This suggests that more HSCs highly expand in the specific lineages where compensation is needed. In addition, we also found that the levels of their expansion increased during compensation. The most abundant clones supplied significantly larger amounts of lymphocytes in the corresponding deficient lineages ( Fig 4I- Figure   S3I -J). Taken together, our data suggest that lineage deficiency is primarily compensated for by highly expanded HSC clones and not by an increase in the total number of differentiating HSC clones.
HSC differentiation is a step-wise process, during which HSCs expand dramatically in number. To identify the differentiation stage at which compensation takes place, we analyzed the number of intermediate progenitors ( Fig 5) , particularly those derived from WT donor HSCs (Appendix Figure S4 ). In both cotransplantation groups, we found a significant increase in the number of common lymphoid progenitors (CLPs) Figure S4 ). As CLPs supply B and T cells, an increase in CLPs to compensate for B cell deficiency will increase T cell production as well. This explains the T-cell compensation that we observed in the uMT -/co-transplantation group ( Figure S4 ).
To determine whether the lymphoid compensation is associated with any molecular level changes in HSCs, we compared the gene expression profiles of WT HSCs from the uMT -/and NSG co-transplantation groups with WT HSCs from the control groups 7-8 months after transplantation. We found that compensating HSCs significantly changed their gene expression profile ( In particular, 96 significantly changed genes are shared between the uMT -/and NSG groups ( Fig 6A) . Genes that change similarly between the uMT -/and NSG co-transplantation groups have been found to be expressed in hematopoietic populations and play roles in regulating lymphopoiesis ( Fig 6B) . For example, PAX5 is a master regulator of B cell differentiation. It represses B-lineage-inappropriate genes and activates B-lymphoid-specific genes 24 . PTPRO is induced by Wnt/β-catenin signaling in a lymphoid enhancer factor dependent manner 25 . IGF1 has been shown to regulate primary B lymphopoiesis 26 . Up-regulation of these genes may be instrumental in priming HSCs to compensate for lymphoid lineages.
To identify biological functions of the differentially expressed genes, we performed Ingenuity Pathway Analysis (IPA) ( Fig 6C-D) . Among the genes that are differentially expressed in both uMT -/and NSG groups, we found significant activation of functions related to response, quantity, and proliferation of lymphocytes ( Fig   6C , Appendix Figure S5 ). The degree of activation is generally higher in the NSG group. We applied the same analysis to each co-transplantation group separately and found that the highest scored diseases, biological functions, and networks are those that are relevant to lymphoid compensation (EV Fig 3-4 ). In addition, we identified interleukin 10 receptor alpha subunit (IL10RA) as an upstream regulator whose expression appears to decrease with NSG and increase with uMT -/co-transplantation ( Fig 6D) . The prediction is based on the comparison of IL10RA downstream target genes and the differentially expressed genes (EV Fig 5) . IL10RA encodes a lymphoid cytokine receptor that has been shown to mediate the immunosuppressive signal of interleukin 10 and inhibit the synthesis of proinflammatory cytokines 27 .
Discussion
In summary, we have presented an experimental model suitable for studying the functional compensation between individual HSCs in vivo. By transplanting different types of stem cells into a single recipient, our mouse model allows for investigating the interactions between stem cells. Similar approaches can be applied to study other tissue and organ systems and to other disease models. Our data demonstrate how the HSC network operates in vivo as a robust coordinated system. The compensation capacities of individual HSCs enable the HSC network to tolerate partial loss of function. Some HSCs quantitatively expand their differentiation to compensate for deficient HSCs and specifically overproduce undersupplied cell types. This suggests that individual HSCs heterogeneously respond to the differentiation deficiencies of other HSCs. This heterogeneous compensation may be essential for maintaining robustness in blood regeneration and suggests that stem cell coordination is a complex process. Furthermore, we have identified cellular and molecular mechanisms underlying the functional compensation between HSCs. In particular, compensation for lymphoid deficiencies is observed at the CLP level and influences the differentiation in other downstream lymphoid lineages. While cellular level compensation manifests itself at the progenitor level, molecular changes have been identified at the stem cell level. We have discovered molecular regulators and pathways in HSCs that are associated with the compensation. Future studies can manipulate these regulatory molecules to improve the efficacy of bone marrow transplantation and to develop new therapeutic strategies exploiting endogenous HSC compensation capacity. New prognosis approaches may be developed by monitoring the compensation activities of endogenous HSCs. A better understanding of stem cell interactions can help improve the treatment of many degenerative and age-related diseases.
Methods

Mice
WT donor mice used in the co-transplantation experiments were C57BL/6J (CD45.2). The lineage deficient donor mice were B6.129S2(B6)-Ighm tm1Cgn /J (uMT -/-, CD45.1), NOD-scid IL2Rgamma null (NSG) and C;129S4-Rag2 tm1.1Flv Il2rg tm1.1Flv /J (Rag2 -/γc -/-, CD45.1). The recipient mice were offsprings of C57BL/6J and B6.SJL-Ptprca Pepcb/BoyJ (F1, CD45.1/ CD45.2). All donor and recipient mice were 8-12 weeks old at the time of transplantation. Irradiation was performed on all recipient mice before transplantation at 950 cGy. We 
Cell Isolation and Transplantation
HSCs (lineage (CD3, CD4, CD8, B220, Gr1, Mac1, Ter119)-/ckit+/Sca1+/Flk2-/CD34-/CD150+) were obtained from the crushed bones of donor mice and isolated using FACS sorting with the FACS-Aria II (BD Biosciences, San Jose, CA) after enrichment using CD117 microbeads (AutoMACS, Miltenyi Biotec, Auburn, CA). HSCs were infected for 15 hours with lentivirus carrying barcodes and then transplanted via retro-orbital injection. HSC clonal labeling was performed as described previously 17 
. Whole bone marrow cells (helper cells)
were flushed from the femurs of F1 mice (CD45.1/ CD45.2) mice and added to HSCs right before transplantation. 250,000 helper cells were transplanted per mouse. For both single deficient and double deficient experiments, we co-transplanted barcoded WT HSCs with uMT -/-HSCs (1:3 and 1:2 ratios) and with Rag2 -/γc -/and NSG HSCs (1:2 ratio). For the control group, we co-transplanted HSCs from WT (CD45.1) and WT (CD45.2) donor mice at the same ratio as the experimental group.
Blood Sample Collection and FACS Analysis
Blood samples were collected into PBS containing 10 mM EDTA via a small transverse cut in the tail vein. To eliminate red blood cells, 2% dextran was added, and the remaining blood cells were treated with ammoniumchloride-potassium lysis buffer on ice for 5 minutes to remove residual red blood cells. After a 30-minute antibody incubation at 4° C, samples were suspended in PBS with 2% FBS and 4,6-Diamidino-2-phenylindole to distinguish dead cells. Cells were sorted using the FACS-Aria I and II cell sorters and separated into granulocytes, B cells, CD4 T cells, and CD8 T cells. Antibodies were obtained from eBioscience and BioLegend as described previously 17 . Donor cells were sorted based on the CD45 marker. The following cell surface markers were used to harvest hematopoietic populations:
Granulocytes: CD4-/CD8-/B220-/CD19-/Mac1+/Gr1+/side scatter high ;
CD8 T cells: B220-/CD19-/Mac1-/Gr1-/TCRαβ+/CD4-/CD8+; HSC (hematopoietic stem cells): lineage (CD3, CD4, CD8, B220, Gr1, Mac1, Ter119)-/ /ckit+/Sca1+/Flk2-/CD34-/CD150+ Flow cytometry data were analyzed using FlowJo software version 9.6.1 (Tree Start, Ashland, OR) and Diva software.
DNA Barcode Extraction and Sequencing
Genomic DNA (gDNA) was extracted from sorted hematopoietic cells and amplified using Phusion PCR mastermix (Thermo Scientific, Waltham, MA). The PCR reactions were halted once they had progressed halfway through the exponential phase. PCR product was purified and analyzed using high-throughput sequencing at the USC Epigenome Center. Sequencing data were analyzed as described 3, 17 . We combined sequencing data with FACS data to generate the clonal abundance for each HSC clone as the percentage of white blood cells.
Clonal abundance =100%* (Donor % in the blood cell population) * (GFP % among donor cells) * (number of reads for each barcode) / (total reads of all barcodes)
RNA Sequencing
Total RNA was isolated from HSCs using the Zymo Research (Irvine, CA) Quick-RNA MicroPrep. A separate mouse was used for each triplicate sample. RNA concentration and integrity was determined by BioAnalyzer 2100(Agilent Technologies) using Agilent RNA 6000 Pico Kit. And libraries were constructed according to the manufacturer's instructions using SMARTer stranded total RNAseq kit or SMART-Seq Ultra Low input RNA Kit (TaKaRa). Each sample was sequenced to produce 40-60 million 75bp single-end reads at the University of Southern California Epigenome Center and Children's Hospital Los Angeles Genomics Core. Data is analyzed by Partek® Flow® software, version 6.0 Copyright© 27 . After adaptor trimming and quality control to treat the raw reads, the clean reads were aligned to mm10 genome and transcriptome reference using STAR 2.5, default parameters. Gene counts module in Partek pipeline was used to quantification gene expression, excluding those whose maximum raw read counts were less than or equal to 10 counts. Differentially expressed genes are identified by the Partek E/M method with fold changes below -2 and greater than 2, and with a P value less than 0.05.
The networks and functional analyses were generated using Ingenuity Pathway Analysis (IPA) 29 Appendix Figure S1 : HSCs compensate for the lineage deficiencies of co-transplanted HSCs in blood production (replicate experiment of Figure 2) .
A-F The production of granulocytes (Gr), B cells, CD4 T cells, and CD8 T cells in the peripheral blood by
WT donor HSCs, competitor donor HSCs (uMT -/and NSG HSCs), and the total cell production are shown as percentages of the total number of white blood cells (WBCs).
Data information: Data were collected at 7 months post transplantation for uMT-/-group and 8 months post transplantation for NSG group, and presented as mean ± SEM. *p < 0.05 (Student's t-test). n = 6 mice for each group.
Appendix Figure S2 : The number of differentiating HSC clones does not change in the presence of lineage deficient HSCs (replicate experiment of Figure 3) .
A-B Total numbers of barcoded HSC clones that give rise to granulocytes (Gr), B cells, CD4 T cells, and
CD8 T cells.
Data information: Data were collected at 7 months post transplantation for uMT-/-group and 8 months post transplantation for NSG group, presented as mean ± SEM. n = 6 mice for each group.
Appendix Figure S3 : C D E Extended View Figure 4 A B 
